Description

Lamivudine/Zidovudine/Nevirapine 150/300/200 mg is a fixed-dose combination medication for HIV treatment. This antiretroviral therapy combines two nucleoside reverse transcriptase inhibitors and a non-nucleoside reverse transcriptase inhibitor, effectively suppressing viral replication and enhancing immune response in HIV-infected individuals.